Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
SOPHiA GENETICS SA Banner

SOPHiA GENETICS SA

SOPH Stock Analysis

Page title

Section title

About SOPHiA GENETICS SA

Medical - Healthcare Information Services
Healthcare

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

SOPHiA GENETICS SA Key Metrics

Market Cap
$225M
52 Weeks Low
$2.70
52 Weeks High
$7.37
P/B
2.01x
P/E
-3.20x
P/S
3.49x

Upcoming Events

    SOPH Analyst Forecasts

    ‌
    ‌

    SOPH Financials

    SOPH Income Statement Key Metrics

    • Revenue(TTM)64.49 M
    • Gross Profit(TTM)43.73 M
    • EBITDA(TTM)-65.64 M
    • Net Income(TTM)-71.40 M
    • EPS Diluted(TTM)-1.0899999999999999

    Decode SOPH's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    SOPH earnings and revenue history

    SOPH Return on Equity

    See how efficiently SOPH generates profit for it's shareholders.

    -52.15%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity Growth

    SOPH's Return on Equity has shown poor growth over the past 10 years, increasing by only -3.29%.

    SOPH Revenue Growth

    See how SOPH has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    SOPH's revenue has grown significantly over the past 10 years, increasing by over 19.72%.